About
Male
Keith-Harrison Dewedoff is the Chief Financial Officer of SpyBiotech. He previously worked at NLS Pharmaceutics AG as an Advisory Board Member. Keith-Harrison Dewedoff attended Northeastern University.
Experience
Series A35Hatfield, Pennsylvania, United StatesBiotech/Pharma · Biotechnology
- Chief Financial Officer · SpyBiotech2024 – present
- Chief Financial Officer · Carbon Biosciences2023 – present
- Board Advisor and CFO · Cell X Technologies2022 – present
- Board Advisor · United Research Laboratories2022 – present
- Chief Financial Officer · Deka Biosciences2022 – present
- Interim CFO · Ceptur Therapeutics2021 – present
- CFO & Advisor · Danforth Advisors2020 – present
- Chief Financial Officer & Co-Founder · Kaizen Bioscience2019 – present
- Board Member, Exec Chair · Kaizen Bioscience2019 – present
- Managing Director, Chief Investment Officer · Kudos Venture Capital2013 – present
Education
- University of Oxford · Nanotechnology, Nanomedicine
- Northeastern University · BS, Management, Economics
People at Code Biotherapeutics
Data from: crunchbase
